Your browser doesn't support javascript.
loading
Dual outflow upper arm arteriovenous fistula: An effective technique to prevent cephalic arch stenosis.
Hwang, Hong Pil; Yu, Hee Chul; Do Yang, Jae; Lee, Mi Rin; Chung, Byeoung Hoon.
Affiliation
  • Hwang HP; Department of Surgery, Jeonbuk National University Medical School, Jeonju, South Korea.
  • Yu HC; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk University Hospital, Jeonju, South Korea.
  • Do Yang J; Department of Surgery, Jeonbuk National University Medical School, Jeonju, South Korea.
  • Lee MR; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk University Hospital, Jeonju, South Korea.
  • Chung BH; Department of Surgery, Jeonbuk National University Medical School, Jeonju, South Korea.
Medicine (Baltimore) ; 102(48): e36419, 2023 Dec 01.
Article in En | MEDLINE | ID: mdl-38050217
ABSTRACT
Cephalic arch stenosis (CAS) is critical point to maintain functional arteriovenous fistula (AVF) in patients undergoing hemodialysis with brachio-cephalic AVFs. In this study, we aimed to determine the effectiveness of dual outflow (cephalic and basilic veins) as a surgical method to prevent CAS. Between July 2016 and December 2019, 369 patients underwent upper arm AVF creation. Among them the 251 patients were enrolled in this retrospective study. Two hundred seven underwent brachio-cephalic arteriovenous fistula (BCAVF) and 44 underwent brachio-cephalicbasilic arteriovenous fistula (BCBAVF). From the 251 patients, diabetes mellitus (66.7% vs 36.4%, P < .001) and hypertension (91.3% vs 75%, P = .002) were more common in the patient group who underwent BCAVF surgery; however, the difference in volume flow to the fistula did not differ between the 2 groups. CAS (30.4% vs 9.1%, P = .004) and fistula occlusion (15.9% vs 4.5%, P = .048) were likely to occur in the BCAVF group. The primary patency rates at 12 months were 74.3% and 86.4% for the BCAVFs and BCBAVFs, respectively (P = .075). The primary-assisted patency rates at 12 months were 87.0% for BCAVFs and 93.2% for BCBAVFs, respectively (P = .145). Secondary patency rates at 12 months were 92.2% for BCAVFs and 93.2% for BCBAVFs, respectively (P = .023). Compared to BCAVF, traditional upper arm AVF, upper arm AVF with cephalic and basilic vein dual drainage can be optimal surgical method to preventing CAS.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteriovenous Shunt, Surgical / Arteriovenous Fistula Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteriovenous Shunt, Surgical / Arteriovenous Fistula Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2023 Document type: Article Affiliation country:
...